One of them presented an episode of hypoglycemia after the initiation of SGLT-2 inhibitors concomitant with the previously prescribed hypoglycemic treatment (GLP-1ra and insulin) and the other patient had repeated episodes of UTI. The gene discussed is SLC5A2; the disease is bacterial urinary tract infection.